Literature DB >> 11134144

Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.

F Cetani1, A Picone, P Cerrai, E Vignali, S Borsari, E Pardi, P Viacava, A G Naccarato, P Miccoli, O Kifor, E M Brown, A Pinchera, C Marcocci.   

Abstract

A reduced expression of calcium-sensing receptor (CaR) messenger ribonucleic acid and protein accompanied by abnormalities in parathyroid cell proliferation and PTH secretion are present in primary hyperparathyroidism. We studied the expression of CaR protein by immunohistochemistry in 36 sporadic parathyroid adenomas and investigated the relationship between CaR expression and several preoperative clinical parameters, including the set-point of Ca(2+)-regulated PTH secretion (measured in vivo). The adenomas were classified in 4 categories according to the intensity of immunohistochemical staining: 5 (14%) showed a CaR staining intensity similar to that of normal parathyroid ( ), 10 (27%) showed moderate staining (++), 16 (45%) showed weak staining (+), and 5 (14%) were negative (-). The intensity of CaR staining was not related to preoperative serum Ca(2+), PTH levels or adenoma volume. Twenty-nine patients underwent preoperatively the calcium infusion test to evaluate the PTH-Ca(2+) set-point. Individual values of PTH-Ca(2+) set-point ranged from 1.38-1.93 mmol/L and were significantly correlated with basal Ca(2+) levels (r = 0.96; P: = 0. 0001) and adenoma volume (r = 0.5; P: = 0.01). The mean PTH-Ca(2+) set-point values were significantly different in the 4 groups of patients classified according to immunohistochemical staining intensity of their adenoma (P: = 0.025; F = 3.78); the mean PTH-Ca(2+) set-point was significantly higher in the groups classified as negative than in those classified as weak or moderate. No correlation was observed between the PTH-Ca(2+) set-point and basal PTH levels or between the percent maximal PTH inhibition and adenoma volume and basal PTH or Ca(2+) levels. In summary, our data suggest that there is a relationship between apparent CaR protein expression and PTH-Ca(2+) set-point abnormality, suggesting that a reduced receptor content might have an important role in the pathogenesis of primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134144     DOI: 10.1210/jcem.85.12.7028

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.

Authors:  Kishiko Nakajima; Ken-Ichi Umino; Yoshiaki Azuma; Seiichi Kosaka; Kazue Takano; Takao Obara; Kanji Sato
Journal:  J Bone Miner Metab       Date:  2009-02-06       Impact factor: 2.626

Review 2.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Adenomatous human parathyroid cells exhibit impaired sensitivity to L-amino acids.

Authors:  H-C Mun; S C Brennan; L Delbridge; M Wilkinson; E M Brown; A D Conigrave
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

4.  Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice.

Authors:  Zhiqiang Cheng; Nathan Liang; Tsui-Hua Chen; Alfred Li; Christian Santa Maria; Michael You; Hanson Ho; Fuqing Song; Daniel Bikle; Chialing Tu; Dolores Shoback; Wenhan Chang
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

Review 5.  Molecular genetics of parathyroid disease.

Authors:  Gunnar Westin; Peyman Björklund; Göran Akerström
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

6.  Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands.

Authors:  Sabrina Corbetta; Marzia Belicchi; Federica Pisati; Mirella Meregalli; Cristina Eller-Vainicher; Leonardo Vicentini; Paolo Beck-Peccoz; Anna Spada; Yvan Torrente
Journal:  Am J Pathol       Date:  2009-07-30       Impact factor: 4.307

7.  Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.

Authors:  Trisha Dwight; Anne E Nelson; George Theodosopoulos; Anne Louise Richardson; Diana L Learoyd; Jeanette Philips; Leigh Delbridge; Jan Zedenius; Bin T Teh; Catharina Larsson; Deborah J Marsh; Bruce G Robinson
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 8.  Calcium-sensing receptor in cancer: good cop or bad cop?

Authors:  Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

9.  Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.

Authors:  A E Cook; S N Mistry; K J Gregory; S G B Furness; P M Sexton; P J Scammells; A D Conigrave; A Christopoulos; K Leach
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

10.  Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism.

Authors:  F Cetani; S Borsari; E Vignali; E Pardi; A Picone; L Cianferotti; G Rossi; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.